|
|
|
|
Product Brochure: MonitorBridge For VMware
As organizations consolidate servers and storage, the applications that depend on this infrastructure must be tested to ensure optimal configuration.To quote VMware, 'problems that can't be measured, can't be repaired.' Enter HP and...
|
|
|
Product Brochure: VMware Lab Manager Add-In For HP Quality Center
HP TestDirector for Quality Center pioneered the management of information related to the testing process.Today, Quality Center is the de facto standard in QA for managing requirements, tests, results, defects and the workflow that...
|
|
|
Lexicon Files Investigational New Drug Application For LX4211 As A Potential Treatment For Diabetes
The Woodlands, TX - Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced recently that it has submitted an investigational new drug (IND)...
|
|
|
PerkinElmer And The European Molecular Biology Laboratory (EMBL) Announce Corporate Partnership To Support EMB
PerkinElmer, Inc Under the terms of the partnership, PerkinElmer will sponsor and have access to the Advanced Training Centre' The recently established EMBL Corporate Partnership Program is designed to create and enhance long-term, effective...
|
|
|
Telik Announces New TRAP Drug Discovery Agreement
Palo Alto, CA - Telik, Inc.announced recently an agreement to provide its TRAP drug discovery technology to investigators at the Hospital for Special Surgery (HSS). The Research Division of HSS studies the mechanisms underlying...
|
|
|
NanoVector To Commercialize First Biologic Nanoparticle Drug Delivery System
NanoVector, Inc.announced today that it has licensed the plant virus nanoparticle drug delivery system developed by Professors' Stefan Franzen and Steven Lommel from North Carolina State University. 'This is breakaway technology that...
|
|
|
Simulations Plus Signs Another Collaboration Agreement
Simulations Plus, Inc.(Nasdaq:SLP), the leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that it has signed a collaboration agreement with a top-three pharmaceutical...
|
|
|
BioSeek Licenses Two Novel Anti-Inflammatory Peptides
BioSeek, Inc., a pioneer in the application of predictive human biology to drug discovery, announced today that it has exclusively licensed two novel anti-inflammatory peptides from Amylin Pharmaceuticals, Inc.The two novel peptides were...
|
|
|
Bionovo Announces Development Plans For Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Me
Emeryville, CA - Bionovo, Inc.recently announced that the FDA has reviewed the company's manufacturing and control process descriptions (CMC), and has provided guidance on how Bionovo can move forward with the development of Menerba ...
|
|
|
Novelix Pharmaceuticals, Inc. Initiates Actinic Keratosis Drug Development Program Based On Topical Use Of NVX
Novelix Pharmaceuticals, Inc.(Novelix), a biopharmaceutical company developing small molecule cancer therapeutics, announced today that it has selected the large-market indication of actinic keratosis (AK) as the main focus of the company...
|
